How many invoice reminders should I send before calling?

Two emails, then a call or a note to the original buyer. Email-only collections stall because AP inboxes are noisy. A short call often reveals a missing PO or a wrong coding string. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

Do founders actually read cold email?

Some do, usually the ones that feel written to their company this week. If you cite a real trigger and keep the ask small, you have a chance. If you mail-merge 'loved your journey,' you don't. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

What subject line works for Pharmaceuticals invoice reminder emails (after a demo)?

Name the situation and the business object, not your excitement. Something like "Founder question on after demo" outperforms "Just checking in" because a founder can decide from the preview text whether it's worth opening. Keep it under 50 characters when you can.

How many times should I follow up with a Founder (after a demo)?

First reminder 3 days after due date, then 7 days, then a call. Same day with the recap. A value bump 3 days later if they went quiet. After that, send a breakup note and archive it. A founder who wants it will answer a clean close more often than a fifth bump.

Should I apologize for sending an invoice reminder?

No. You can be polite without acting like asking to be paid is a favor. State the facts, offer help if something is blocked, and keep the next step obvious. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

Pharmaceuticals · Founder · After Demo

Invoice Reminder for Pharmaceuticals Founder: After Demo

When a Pharmaceuticals Founder goes quiet (after a demo), the right invoice reminder email does one job: make a reply cheaper than silence. They context-switch constantly and reply to emails that reduce uncertainty. They can smell a template that was also sent to 400 peers. That's why this template leads with time through MLR, access, and compliant engagement rates instead

Last updated: 2026-09-02 · Reviewed by: Sales Email Template editors

We write templates the way we wrote emails on quota: short, specific, and easy to forward. When we cite research below, it is because the number changes how a buyer reads your note, not to pad the page.

Sources: HubSpot sales email benchmarks; Gong follow-up research

Why does this invoice reminder work for a Pharmaceuticals Founder?

Keep emotion out of it. Money emails should feel operational.
Speaks to follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick instead of a generic "value prop."
Fits how a founder actually reads: Short, vivid, one proof point max.
Replay the two moments they leaned in, and the one concern they named.
Assume process failure before bad intent.

When should I send this to a Pharmaceuticals Founder?

First reminder 3 days after due date, then 7 days, then a call. Same day with the recap. A value bump 3 days later if they went quiet. For this combo, treat "Same day, then 3 days if silent" as the default, then adjust around launch calendars and review boards set speed. you don't. If you're emailing a founder, Short, vivid, one proof point max. Tuesday through Thursday mid-morning local time is a safe default.

What this Founder actually cares about

A founder in Pharmaceuticals is protecting runway, focus, and the company's early reputation. They context-switch constantly and reply to emails that reduce uncertainty. They can smell a template that was also sent to 400 peers. The hook that earns a look is a problem they personally still own because the team is small. The ask should stay at this size: a yes/no on timing, or a 15-minute working chat. Delete trigger: Calling them a 'decision maker' or pitching like they're a Fortune 500 process. If your note would embarrass them in a team channel, rewrite it.

How Pharmaceuticals changes the note

Pharmaceuticals buyers are commercial, medical, and ops leads who work under review boards and long timelines. Don't invent clinical claims. Don't treat HCPs like a funnel. If you don't know the rules, your email is a liability. A credible proof point in this vertical sounds like: cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. Watch the language. Words that land here include MLR, label, access, HCP, congress, promotional review. Buyers here measure success with time through MLR, access, and compliant engagement rates. Buyers here measure success with time through MLR, access, and compliant engagement rates.

How should I customize this template before I send it?

Replace the pain line with an agency waiting on MLR while the sales team keeps asking 'is it approved yet'.
Keep the tone human and specific.
Send from a person, not noreply.
Time it for Same day, then 3 days if silent. Same day with the recap. A value bump 3 days later if they went quiet.
Don't use consumer-startup slang. It's a credibility leak.

What mistakes should I avoid with this after demo note?

Being cute about money makes you look unserious.
Don't send a 19-page deck that relitigates features they skipped.
Don't use consumer-startup slang. It's a credibility leak.
Calling them a 'decision maker' or pitching like they're a Fortune 500 process.

How does this after demo scenario compare?

Dimension	For this template
Best send window	Same day, then 3 days if silent
Ideal length	Short, vivid, one proof point max.
Primary ask	a yes/no on timing, or a 15-minute working chat
Industry metric to cite	time through MLR, access, and compliant engagement rates
Tone	Human and specific. Peer to peer, not vendor to 'target.'
Unlike after meeting	They have product context now. Speak to what they saw, not to a generic intro.
Unlike after proposal	Pricing may not be on paper yet. Don't jump to 'ready to sign.'

What should I copy and send?

Copy-ready template

Subject

Founder question on after demo

Body

Hi [First Name],

This is a reminder, not a scare note. Invoice [number] is still open.

The version of this that matters for commercial, medical, and ops leads who work under review boards and long timelines is cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. Pay here: [link]. Invoice PDF is attached / linked. If the PO, coding, or approver is the blocker, tell me and I'll fix our side today.

Replay the two moments they leaned in, and the one concern they named.

Who on your side should I talk to if this isn't your queue?

Best,
[Your Name]
[Your Title]
[Your Company]

Questions people ask before they hit send

Lead with time through MLR, access, and compliant engagement rates. That's the language this buyer already reports. If you can't connect your email to follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick, you're asking them to do the translation work. They won't.

Related templates

Want a custom draft instead? Try the email generator.